NCT03257007

Brief Summary

The MEANING trial is a randomized controlled mixed methods pilot designed to compare a novel mindfulness meditation-based intervention (MEANING) to usual care for adults with advanced-stage solid malignancies and their family caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 22, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2017

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

7 months

First QC Date

August 16, 2017

Last Update Submit

August 10, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in quality of life (QoL) for Patients

    QoL for patients will be assessed with the McGill Quality of Life Inventory.

    Baseline, 6 weeks, and 10 weeks

  • Change from baseline in quality of life (QoL) for Family Caregivers

    QoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).

    Baseline, 6 weeks, and 10 weeks

Secondary Outcomes (15)

  • Change from baseline in advance care planning (ACP) stage of change

    Baseline, 6 weeks, and 10 weeks

  • Change from baseline in advance care planning (ACP) engagement

    Baseline, 6 weeks, and 10 weeks

  • Change from baseline in caregiver burden

    Baseline, 6 weeks, and 10 weeks

  • Change from baseline in avoidant coping

    Baseline, 6 weeks, and 10 weeks

  • Change from baseline in avoidant coping

    Baseline, 6 weeks, and 10 weeks

  • +10 more secondary outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

Participants assigned to Usual Care will continue to receive standard care from their oncology team, including access to supportive care from oncology social workers. At the end of the study, usual care dyads will receive a packet of informational materials on mindfulness meditation, receive a CD with 5 mindfulness meditation practices, and meet with the study interventionist for guidance on how to use the materials and mindfulness recordings to their advantage in coping with cancer-related challenges.

Mindfulness

ACTIVE COMPARATOR

The Mindfulness intervention will consist of six 2-hour sessions that will include guided mindfulness practices, didactics, and group discussion. The course curriculum is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.

Behavioral: Mindfulness

Interventions

MindfulnessBEHAVIORAL

The Mindfulness intervention sessions are designed to cultivate present-moment awareness in everyday life to facilitate adaptive and non-reactive relating to thoughts, feelings, and bodily sensations. Participants will be provided with 10-20 minute audio recordings of each of 5 mindfulness practices covered in class, recorded in the facilitator's voice. Participants will be encouraged to practice mindfulness at home 10-20 minutes per day, 6 days per week. Participants will be provided with weekly diaries on which to record type and amount of home practice of mindfulness skills.

Mindfulness

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is at least 18 years of age.
  • Patient is at least 3 weeks post-diagnosis of an incurable (locally advanced or metastatic) solid malignancy.
  • Patient's attending medical oncologist would not be surprised if the patient died in the next 12 months.
  • Patient has not completed a POST form.
  • Patient scores ≥ 7 on the Mini-Mental Adjustment to Cancer cognitive avoidance subscale.
  • Patient is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
  • Patient has a family member or close friend eligible and interested in participating in the study.
  • Patient has adequate English fluency for completion of data collection
  • FCG is at least 18 years of age.
  • FCG has been invited to participate in the trial with a patient who meets eligibility criteria above.
  • FCG is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
  • FCG has adequate English fluency for completion of data collection

You may not qualify if:

  • Patient reports a score of \> 2 on the Activities and Function item from the Patient Generated Subjective Global Assessment91 (PG-SGA; the patient-reported version of the Eastern Cooperative Oncology Group score).
  • Patient makes 3 or more errors on a validated 6-item cognitive screener or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
  • Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).
  • FCG exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Indianapolis, Indiana, 46202, United States

Location

Related Publications (1)

  • Mosher CE, Beck-Coon KA, Wu W, Lewson AB, Stutz PV, Brown LF, Tang Q, Helft PR, Levoy K, Hickman SE, Johns SA. Mindfulness to enhance quality of life and support advance care planning: a pilot randomized controlled trial for adults with advanced cancer and their family caregivers. BMC Palliat Care. 2024 Sep 28;23(1):232. doi: 10.1186/s12904-024-01564-7.

MeSH Terms

Conditions

Neoplasm Metastasis

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Shelley A Johns, PsyD

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants are blind to study hypotheses.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be assigned in equal numbers using block randomization to the mindfulness intervention or usual care. The course curriculum for the mindfulness intervention is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine, Research Scientist

Study Record Dates

First Submitted

August 16, 2017

First Posted

August 22, 2017

Study Start

May 9, 2017

Primary Completion

December 11, 2017

Study Completion

December 11, 2017

Last Updated

August 12, 2020

Record last verified: 2020-08

Locations